- Home
- PL vs BLFS Comparison
PL vs BLFS Comparison
Compare PL & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PL
- BLFS
- Stock Information
- Founded
- PL 2010
- BLFS 1987
- Country
- PL United States
- BLFS United States
- Employees
- PL N/A
- BLFS N/A
- Industry
- PL Aerospace
- BLFS Medical/Dental Instruments
- Sector
- PL Industrials
- BLFS Health Care
- Exchange
- PL Nasdaq
- BLFS Nasdaq
- Market Cap
- PL 947.7M
- BLFS 1.0B
- IPO Year
- PL N/A
- BLFS 1989
- Fundamental
- Price
- PL $6.86
- BLFS $22.84
- Analyst Decision
- PL Buy
- BLFS Strong Buy
- Analyst Count
- PL 12
- BLFS 7
- Target Price
- PL $5.97
- BLFS $30.57
- AVG Volume (30 Days)
- PL 16.6M
- BLFS 658.4K
- Earning Date
- PL 06-04-2025
- BLFS 08-07-2025
- Dividend Yield
- PL N/A
- BLFS N/A
- EPS Growth
- PL N/A
- BLFS N/A
- EPS
- PL N/A
- BLFS N/A
- Revenue
- PL $250,177,000.00
- BLFS $87,762,000.00
- Revenue This Year
- PL $14.85
- BLFS $21.21
- Revenue Next Year
- PL $21.22
- BLFS $17.58
- P/E Ratio
- PL N/A
- BLFS N/A
- Revenue Growth
- PL 9.52
- BLFS 34.80
- 52 Week Low
- PL $1.73
- BLFS $18.70
- 52 Week High
- PL $7.72
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- PL 79.11
- BLFS 57.04
- Support Level
- PL $5.92
- BLFS $21.13
- Resistance Level
- PL $7.72
- BLFS $22.07
- Average True Range (ATR)
- PL 0.48
- BLFS 0.91
- MACD
- PL 0.07
- BLFS 0.13
- Stochastic Oscillator
- PL 69.17
- BLFS 88.73
About PL Planet Labs PBC
Planet Labs PBC is an Earth-imaging company. The company provides daily satellite data that helps businesses, governments, researchers, and journalists understand the physical world and take action.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.